Interleukin-12 (IL-12) orchestrates acquired resistance in intracellular
In experimental Leishmania donovani infection in the liver, granuloma assembly, activated macrophage parasite killing, and responses to conventional antimony (Sb) chemotherapy are regulated by mechanisms which govern gamma interferon (IFN-␥) production (7, 19, 21, 35) . Although capable of IFN-␥-independent action (2, 18, 32), interleukin-12 (IL-12 [IL12p70, composed of p35 and p40 subunits]) is a primary stimulus for L. donovani-induced IFN-␥ (2, 15, 17, 32) ; thus, each of the preceding antileishmanial effects is also regulated by IL-12 (2, 17) . Nevertheless, other cytokines, acting alone or with IL-12, also help to shape acquired resistance and/or promote IFN-␥ secretion (3, 5, 8, 13, 14, 16, 18, 30, 31, 33, 34) ; IL-2, IL-4, and tumor necrosis factor, for example, have already been identified as being active in the initial defense against L. donovani (14, 20, 29) .
To test roles of two other potential IFN-␥-inducing cytokines, IL-23 and IL-18 (8, 13, 18, 25, 26, 30, 31) , the following types of female mice were infected with 1.5 ϫ 10 7 intravenously injected, hamster spleen-derived L. donovani amastigotes (1 Sudan strain): (a) wild type (WT), IL-12p35
Ϫ/Ϫ (deficient in IL-12 and IL-23, the latter composed of p40 and p19 (25) (C57BL/6 background) (24) . WT BALB/c and C57BL/6 mice respond similarly to L. donovani (21) and, as anticipated, showed initial susceptibility and then self-cure by week 8 (Fig. 1 ). This acquired resistance response is associated with induction of IL-12p40 and IFN-␥ mRNA expression in liver tissue (2, 11, 22) and increases in IFN-␥ and IL-12p40 and p70 in serum at weeks 2 to 4 (17, 23, 27, 29, 32) . In livers of BALB/c mice, used here as representative of WT animals, p19 mRNA (IL-23 marker) was detected in uninfected mice, and expression was not increased by L. donovani infection (week 3, semiquantitative reverse transcription-PCR normalized to HRPT expression, not shown). While IL-18 mRNA was also expressed constitutively (10), its expression increased at weeks 2 and 4 in infected animals ( Fig. 2) . IL-12p35 Ϫ/Ϫ mice show enhanced susceptibility to L. donovani (18, 24) and, as illustrated in Fig. 1A , developed highlevel, noncuring infection. Since IL-23 and IL-18 are preserved in p35
Ϫ/Ϫ mice (1, 9, 13, 26), apparently, neither could compensate for IL-12's overall antileishmanial effect (2, 12, 17, 18) . In addition, initial kinetics of parasite replication in IL-12p35 (Fig. 1A) .
In contrast, IL-18 Ϫ/Ϫ mice controlled liver infection by week 12 (Fig. 1B) . However, susceptibility to L. donovani was clearly increased initially, compared to WT animals (e.g., at week 4), and liver parasite burdens were still 13-fold higher at week 8 in IL-18 Ϫ/Ϫ mice. These results point to a separate IL-12/IL-23-independent role for IL-18, since IL-12 and presumably IL-23 expression is intact in IL-18-deficient mice (12, 26) . While the latter controlled infection at week 12, IFN-␥ Ϫ/Ϫ mice (19, 24) infected in parallel did not (Fig. 1B) , indicating stimuli other than IL-18 for IFN-␥ production in this model (see the next paragraph).
Increased IFN-␥ levels were detected in serum on days ϩ14 and ϩ21 in both infected BALB/c and C57BL/6 WT mice (Fig. 3) . Attesting to IL-12's role in IFN-␥ secretion in L. donovani infection (2, 15, 17, 28) , serum IFN-␥ was undetectable initially in both IL-12p35 Ϫ/Ϫ and p40 Ϫ/Ϫ animals, although low levels were detected on day ϩ28 at 20 Ϯ 19 and 8 Ϯ 8 pg/ml, respectively (four mice per group). In contrast, IFN-␥ levels in infected IL-18 Ϫ/Ϫ mice were not different from WT controls (P Ͼ 0.05). While the measuring of IFN-␥ in serum is a useful marker of Th1-cell-type responses, the physiologic implication of activity in serum (versus in situ IFN-␥ expression at the infected tissue focus) is unknown. However, in view of initially enhanced susceptibility to L. donovani in IL-18 Ϫ/Ϫ mice (Fig. 1B) , preserved IFN-␥ secretion suggested an early-acting, IFN-␥-indepen-dent antileishmanial effect for endogenous IL-18, as reported in other models (26) . Such a mechanism might involve the effects of tumor necrosis factor (32) .
In addition to macrophage activation and control of infection, the IFN-␥-mediated, IL-12-driven Th1-cell response also induces granuloma assembly in parasitized liver (17, 21, 28) and regulates the leishmanicidal activity of Sb (19) . Therefore, seeking differences between IL-12p40 Ϫ/Ϫ and p35 Ϫ/Ϫ mice and between IL-18 Ϫ/Ϫ and WT mice, we examined histologic reactions (Fig. 4) and Sb-induced parasite killing (Table 1) .
Granuloma assembly in the liver correlated with outcome of infection: (i) BALB/c and C57BL/6 WT mice generated numerous mature-appearing granulomas by weeks 2 through 4 at Ͼ90% of parasitized foci, (ii) few granulomas developed in either IL-12p35 Ϫ/Ϫ or p40 Ϫ/Ϫ mice by weeks 8 through 12, and (iii) while initially suppressed at week 2, IL-18 Ϫ/Ϫ animals expressed a granulomatous response by week 4 which was well developed by week 8 (Fig. 4) . The tissue responses in IL12p35 Ϫ/Ϫ and p40 Ϫ/Ϫ mice were not discernibly different. In both, heavily infected foci showed few recruited mononuclear cells, nearly indistinguishable from the absent inflammatory reaction in livers of BALB/c IFN-␥ Ϫ/Ϫ mice 8 to 12 weeks after infection (not shown) (21) . Similarly, and also akin to IFN-␥ Ϫ/Ϫ mice (19), the parasite-killing response to Sb chemotherapy was comparably impaired in IL-12p40 Ϫ/Ϫ and p35 Ϫ/Ϫ mice (Table 1) . In contrast, IL-18 Ϫ/Ϫ animals responded normally to treatment, likely reflecting intact production of IFN-␥, which regulates the Sb effect (19) .
While IL-12p40 Ϫ/Ϫ mice are known to be susceptible to L. donovani (28, 36) , this and a previous study with IL12p35 Ϫ/Ϫ mice (18) make it clear that the central position occupied by IL-12 in acquired resistance to L. donovani cannot be compensated for by other cytokines, including IL-18. At the same time, however, our results also suggest that the spectrum of cytokines which exert IL-12-independent regulatory roles in visceral infection (5, 10, 19, 20, 35) can be expanded to include IL-18 and probably IL-23. Since animals deficient in IL-23 alone (e.g., p19
Ϫ/Ϫ mice) (8, 25) have not yet been tested, a role for IL-23 in the absence of IL-12 can only be inferred from the data derived in IL12p40 Ϫ/Ϫ mice. In this setting, IL-23 exerts an apparent antileishmanial effect in late-stage visceral infection. Since p35 Ϫ/Ϫ mice, deficient in IL-12 alone, showed near-absent IFN-␥ and granuloma responses, testing in p19 Ϫ/Ϫ mice will be important to better clarify IL-23's role and mechanism which may involve induction of cytokines other than IFN-␥ (8). In contrast, the IL-18-dependent antileishmanial mech- a Two weeks after infection (day ϩ14), liver parasite burdens were determined and mice were injected once with Sb (500 mg/kg of body weight). Results are from two to three experiments and indicate mean Ϯ standard error of the mean values for 7 to 13 mice per group per time point. Day ϩ21 results for untreated mice (0% killing in all groups) were omitted for brevity.
b LDU, Leishman-Donovan units. 
